CIBC World Market
EDSA icon

CIBC World Market’s Edesa Biotech EDSA Stock Holding History

CIBC World Market’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,999
Closed -$48.8K – 1401
2025
Q1 		$48.8K Buy
+19,999
New +$43.1K ﹤0.01% 1328
2024
Q3 		– Sell
-10,770
Closed -$46K – 1336
2024
Q2 		$46K Buy
+10,770
New +$48K ﹤0.01% 1241
2023
Q4 		– Sell
-7,804
Closed -$239K – 1263
2023
Q3 		$239K Hold
7,804
– – ﹤0.01% 1093
2023
Q2 		$44K Buy
+7,804
New +$51.9K ﹤0.01% 1185

Other funds holding EDSA

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CIBC World Market's EDSA Position: Q2 2025 in Review

CIBC World Market sold out of Edesa Biotech (EDSA) in Q2 2025, closing a stake of 19,999 shares — an estimated $48.8K sold.

CIBC World Market first reported a position in EDSA in Q2 2023 and held it in 4 quarters. The position peaked at $239K in Q3 2023. 20 funds tracked by Wall St. Rank hold EDSA as of Q2 2025.

  • CIBC World Market reported no remaining Edesa Biotech position as of Q2 2025 after selling out during the quarter.
  • CIBC World Market sold 19,999 Edesa Biotech shares in Q2 2025, an estimated $48.8K.
  • CIBC World Market first reported a position in Edesa Biotech in Q2 2023 and held it in 4 quarters.
  • CIBC World Market's Edesa Biotech position peaked at $239K in Q3 2023.
  • 20 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2025.

Based on CIBC World Market's 13F filing for Q2 2025, filed 14 Aug 2025.